Knect365 is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

'We really have to take out the complexity that has been over-engineered into clinical trials' - Rob DiCicco, VP at GSK

We spoke to Rob DiCicco, Vice President of Clinical Innovation & Digital Platforms at GSK, on the hottest topics in clinical trials and how he sees them changing in the next year.

Speaking exclusively at Partnerships in Clinical Trials Europe 2016, DiCicco explores:

  • Patient-centricity: 'We need an end-to-end strategy for patient engagement... If we ask to monitor them 24/7 over the course of a clinical trial and ask them to share all kinds of data, then we owe it to them to get them their trial results in a timely fashion.'
  • Technology: 'The application of Big Data analytics ought to inform the development of clinical trial protocols... and help to drive decision making to streamline trials.'
  • Challenges: 'We really have to take out the complexity that has been over-engineered into clinical trials.'
  • Changes in 2017: 'I think you'll see technology companies try to evolve things that look like Electronic Health Record connectors.'

Watch the full interview below or here.

Get articles like this by email